ArticleCell cycle (Georgetown, Tex.)2021

Perspective: targeting VEGF-A and YKL-40 in glioblastoma - matter matters.

Camilla Bjørnbak Holst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.